M4MM
Curaleaf Secures Australian Approval for Medical Cannabis Inhaler, Lists in New Zealand
LONDON – Curaleaf International, part of Curaleaf Holdings, Inc., in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Device (QMID) has been registered by Australia's Therapeutic Goods Administration (TGA) as a Class ...
BetterLife Closes $100M Offering for Neurological Drug Pipeline
VANCOUVER – BetterLife Pharma Inc. closed a US$100 million public offering, providing capital to take its lead candidate through Phase I and Phase II clinical trials for cluster headache and migraine. Deep Track Capital led ...
DEA Judge Stalls Cannabis Rescheduling Over Process Gaps Report
WASHINGTON – Federal adult-use Cannabis rescheduling is at a standstill. Again. This time, the trigger is a government audit that found the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) have long ...
Trulieve Earns Its Spot on the S&P Indices
TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...
GTI Bets on Its Own Stock, Again
CHICAGO – Green Thumb Industries Inc. announced that its board of directors had authorized a $50 million share repurchase program – the company's third consecutive buyback initiative since 2023. Under the new program, Green Thumb ...
Vireo Growth Completes M3 Wellness Acquisition
MINNEAPOLIS – Vireo Growth Inc. announced the completion of its acquisition of M3 Wellness, a retail Cannabis dispensary in Hawthorne, NV. Structured as an indirect asset purchase from M3 Wellness, LLC under an agreement signed ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Big Pharma stopped dipping its toe and dove in headfirst. A $3.8 billion psychedelic acquisition closed. A hostile Cannabis takeover escalated into a full public war of facts and figures, with a ...
Curaleaf Secures Australian Approval for Medical Cannabis Inhaler, Lists in New Zealand
LONDON – Curaleaf International, part of Curaleaf Holdings, Inc., in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Device (QMID) has been registered by Australia's Therapeutic Goods Administration (TGA) as a Class ...
BetterLife Closes $100M Offering for Neurological Drug Pipeline
VANCOUVER – BetterLife Pharma Inc. closed a US$100 million public offering, providing capital to take its lead candidate through Phase I and Phase II clinical trials for cluster headache and migraine. Deep Track Capital led ...
DEA Judge Stalls Cannabis Rescheduling Over Process Gaps Report
WASHINGTON – Federal adult-use Cannabis rescheduling is at a standstill. Again. This time, the trigger is a government audit that found the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) have long ...
Virginia Cannabis Licenses Delayed Again After Spanberger Veto
RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in ...
Planet 13 Secures Florida Approval for BHO Extraction Lab
LAS VEGAS – Planet 13 Holdings Inc. announced that it has received approval from the Florida Office of Medical Marijuana Use (OMMU) for its butane hash oil (BHO) extraction facility in the state. The approval ...
FDA Grants Breakthrough Designation to Vertanical Cannabis-Based Pain Drug
BERLIN – The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to VER-01, a Cannabis-derived, non-opioid investigational drug developed by Germany's VERTANICAL for the treatment of chronic low back pain. VER-01 is ...
Apollo Acquires Emerald in $1.5B Deal: What’s Next for MJBizCon?
LOS ANGELES – Apollo Global Management Inc., one of the world's most powerful alternative asset firms, announced that its managed funds have entered into definitive agreements to acquire Emerald Holding, Inc., the owner of MJBizCon ...
Ascend Wellness Shuts Down Lansing Cultivation Facility
LANSING – In a move that reflects ongoing adjustments in Michigan’s Cannabis sector, Ascend Wellness Holdings is shutting down operations at its Lansing cultivation site. The decision comes after a fire late last year and ...
Cannabis and Alcohol Push Back Against Proposed Hemp Regulation Bill
WASHINGTON – Competing industry interests are shaping the debate over federal hemp policy as lawmakers weigh alternatives to an impending ban on many hemp-derived products. A new legislative effort highlights the tensions between established markets ...
Research and Markets Report Sets a $28B Target on Cannabis Tech
DUBLIN – The Cannabis industry has transformed from plant cultivation to infrastructure development. Today, institutional-grade technologies reshape the way the global supply chain works, and the numbers behind this evolution are capturing the attention of ...
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential in Europe's regulated medical Cannabis market as more countries refine access rules and patient numbers climb. The analysis from IMARC Group points to steady expansion ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among ...
Definium Doses First Patient in Second Phase 3 LSD-Based Trial
NEW YORK – Definium Therapeutics Inc. has taken another step forward in its late-stage testing of a psychedelic-derived treatment for major depressive disorder. The company announced that the first participant received a dose in the ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale ...
